Jindal IVF, a leading institute in Assisted Reproductive Technology (ART) and In Vitro Fertilization (IVF), marks a groundbreaking achievement in reproductive medicine. With the successful completion of the Preimplantation Genetic Testing for Human Leukocyte Antigen (PGT-HLA) case, Jindal IVF has demonstrated its commitment to pushing the boundaries of innovation and providing hope to families facing genetic challenges.